Wolters Kluwer, NL0000395903

Wolters Kluwer stock trades near record levels as recurring revenue and margins stay strong

Published on 07/21/2026 at 04:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Wolters Kluwer stock benefits from a high share of recurring digital revenues and expanding margins, with investors watching earnings growth and cash generation alongside the share price near its 52-week high.

Modernes Glasbürogebäude am Kanal, Fachverlag Wolters Kluwer N.V., NL0000395903
Wolters Kluwer N.V. (NL0000395903) verkörpert modernes Fachverlagswesen an ruhigem niederländischem Sitz mit Glasarchitektur, Illustration mit AI erstellt.

Wolters Kluwer stock has been supported by robust earnings and cash generation, with the Dutch information services group (ISIN NL0000395903) reporting solid growth in recent periods and trading close to its recent highs. In its results for fiscal 2024, Wolters Kluwer reported higher revenues, improved margins, and stronger earnings, underlining the importance of its digital and expert solutions portfolio for investors.

Revenue grows and margins improve

According to Wolters Kluwer's investor information for fiscal 2024, the group generated annual revenues of approximately EUR 5.0 billion, reflecting continued expansion of its digital information, software, and services offerings. The company reported that a substantial majority of its revenues now come from digital and subscription-based products, which tend to be recurring and provide greater visibility for future cash flows.

In the same fiscal period, Wolters Kluwer reported operating profit and margin improvements compared with the previous year, supported by efficiency measures and a shift to higher-value expert solutions. The company's operating margin increased by several percentage points versus fiscal 2023, indicating that incremental revenue is flowing more strongly to the bottom line. For investors, the combination of revenue growth and margin expansion is a key driver of earnings per share and valuation multiples.

Earnings and cash flow support valuation

Wolters Kluwer's earnings per share in fiscal 2024 rose compared with the prior year, driven by higher operating income and disciplined capital allocation, including share repurchases and selective bolt-on acquisitions. Net income for the year reached well above EUR 1.0 billion, illustrating the scale of the business and the profitability of its core segments in professional information and software.

The company also reported strong free cash flow generation for fiscal 2024, with cash flows supporting dividends and share buybacks. Free cash flow for the year amounted to several hundred million euros, comfortably covering the dividend and providing capacity for ongoing investment. This cash generation is supported by the high share of recurring subscription revenues and relatively asset-light operations, which together underpin a resilient financial profile.

Recurring digital revenues above 80 percent

Over recent years, Wolters Kluwer has emphasized the transition from print-based and transactional offerings to digital, cloud, and expert solutions. As of fiscal 2024, more than eighty percent of the group's revenues were derived from digital products and services, including cloud software, expert solutions, and online information platforms. This steady digitalization has helped stabilise revenue streams and reduce volatility tied to individual project work.

The company's investor materials highlight that more than three quarters of revenues are subscription-based or recurring, providing a foundation for long-term planning and improving earnings predictability. This recurring model is particularly relevant for investors assessing Wolters Kluwer stock, since it supports valuation based on durable cash flows rather than one-off contracts or cyclical demand spikes.

Segment growth and portfolio mix

Wolters Kluwer's portfolio is organised into major business segments such as Health, Tax & Accounting, Governance, Risk & Compliance, and Legal & Regulatory, each contributing to overall growth and profitability. In fiscal 2024, several segments reported mid-single to low-double-digit organic growth rates, with Health and Tax & Accounting typically among the stronger performers due to demand for clinical decision support and compliance software.

Year on year, the Health segment reported an increase in revenues supported by clinical decision support tools and electronic health record integration, while Tax & Accounting benefited from rising adoption of cloud-based tax and accounting platforms. These segment trends illustrate how Wolters Kluwer is positioned to benefit from longer-term shifts in professional workflows towards digital and automated solutions.

Dividend growth and shareholder returns

Wolters Kluwer has a track record of increasing its dividend over time alongside earnings growth, and in fiscal 2024 the group again raised its dividend per share compared with the prior year. The dividend increase was supported by higher net income and strong free cash flow, and reflected the board's confidence in the company's long-term earnings power.

Alongside dividends, Wolters Kluwer has used share repurchases to return capital to shareholders in recent years. The combination of dividend growth and buybacks means that total shareholder returns are supported by both income and reductions in the share count, provided earnings continue to grow. This capital allocation strategy can be an important factor in how investors value Wolters Kluwer stock over the medium term.

Market capitalization and valuation context

Based on recent trading levels and the number of shares outstanding, Wolters Kluwer's market capitalization stands in the tens of billions of euros, placing the company among the larger listed information services and professional software providers in Europe. The stock's valuation, measured through earnings multiples and free cash flow yield, reflects both the stability of its recurring revenues and the growth potential in digital expert solutions.

For instance, the price-to-earnings ratio derived from fiscal 2024 earnings suggests that investors are willing to pay a premium compared with traditional print or transactional businesses, in exchange for exposure to subscription-based, software-driven growth. Similarly, the free cash flow yield indicates how much cash the company generates relative to its equity value, a measure closely watched by investors focused on long-term returns.

Shares near 52-week high

Wolters Kluwer stock is traded on Euronext Amsterdam, where it has reached new highs in recent periods. As of early 2026, the share price was near its 52-week high, underpinned by solid financial performance and a favorable perception of its digital transformation. The proximity of the stock to its yearly high highlights investors' confidence in the company's business model and financial outlook.

Compared with its 52-week low, the share price has risen significantly over the period, reflecting a re-rating on the back of earnings growth and recurring revenue visibility. Such a move also positions Wolters Kluwer stock as a reference point in the European information services sector, where investors compare valuation and growth prospects across peers.

Read more about Wolters Kluwer

Read deeper

Further details on Wolters Kluwer

Investors can find more detailed figures, segment breakdowns, and strategic updates on Wolters Kluwer through dedicated company and investor information pages.

Health segment driven by UpToDate

Within Wolters Kluwer's Health division, a central product is UpToDate, a clinical decision support resource aimed at physicians and healthcare professionals. UpToDate provides continuously updated, evidence-based medical content to support diagnosis and treatment decisions at the point of care. The product is distributed through subscriptions and integrated into hospital systems and electronic health records.

UpToDate has contributed meaningfully to the growth of the Health segment, as rising subscriptions and international expansion have increased revenues and enhanced the division's margins. For healthcare providers, the product supports quality of care and can help standardize clinical practice across institutions. For Wolters Kluwer, UpToDate exemplifies the strategy of combining authoritative content with technology to deliver expert solutions that command premium pricing and long-term contracts.

Wolters Kluwer stock on Euronext Amsterdam

Wolters Kluwer stock is listed on Euronext Amsterdam under the ticker symbol AMS: WKL. The shares are traded in euros and are included in major indices, reflecting the company's size and sector relevance. The stock's liquidity on the Amsterdam exchange allows both institutional and retail investors to adjust positions based on their view of the company's earnings and long-term prospects.

The latest available share price on Euronext Amsterdam, as of a recent trading day, showed Wolters Kluwer stock near its 52-week high, indicating a strong performance over the preceding twelve months. This price level, combined with the company's market capitalization, positions Wolters Kluwer among the leading European-listed information services and professional software businesses.

Key data on Wolters Kluwer stock

  • Company: Wolters Kluwer N.V.
  • ISIN: NL0000395903
  • Ticker: AMS: WKL
  • Trading venue: Euronext Amsterdam
  • Price (as of 1 June 2026, 16:30 CET): EUR 140.00
  • Market capitalization: EUR 24.0 billion (as of 1 June 2026)
  • Sector / Industry: Professional information services / software and content
  • Index membership: AEX
  • Next earnings date: 30 July 2026

Follow Wolters Kluwer stock on social platforms

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | NL0000395903 | WOLTERS KLUWER | boerse | 69817134 | bgmi